Exosome injection safety checked in small study
NCT ID NCT06429033
First seen Jan 07, 2026 · Last updated Jun 06, 2026 · Updated 24 times
Summary
This early-stage study tested whether a purified exosome product (PEP) is safe when injected into the skin of healthy adults. Eight participants received the injection and were monitored for side effects. The goal was to check for any immediate reactions or lab changes, not to treat a disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Testing of Beverly Hills
Encino, California, 91436, United States
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.